Kuros Biosciences raises €24.4M Series C round
23 January 2002· Schlieren, Switzerland· health, orthobiologics, biotech, materials, b2b, deep_hardware
Investors
LeadHBM Healthcare Investments
Also participating
Adamant Biomedical Investments
About Kuros Biosciences
Stage
Growth
Headquarters
Schlieren, Switzerland
Founded
2000
Team Size
51–200
Sectors
healthorthobiologicsbiotechmaterialsb2bdeep_hardware